These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 19467574)

  • 1. From the "little brain" gastrointestinal infection to the "big brain" neuroinflammation: a proposed fast axonal transport pathway involved in multiple sclerosis.
    Deretzi G; Kountouras J; Grigoriadis N; Zavos C; Chatzigeorgiou S; Koutlas E; Tsiptsios I
    Med Hypotheses; 2009 Nov; 73(5):781-7. PubMed ID: 19467574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of brain and spinal cord atrophy in multiple sclerosis.
    Minagar A; Toledo EG; Alexander JS; Kelley RE
    J Neuroimaging; 2004 Jul; 14(3 Suppl):5S-10S. PubMed ID: 15228754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathophysiology of multiple sclerosis].
    Smith KJ
    Rev Prat; 2006 Jun; 56(12):1299-303. PubMed ID: 16948217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remodeling of axonal connections contributes to recovery in an animal model of multiple sclerosis.
    Kerschensteiner M; Bareyre FM; Buddeberg BS; Merkler D; Stadelmann C; Brück W; Misgeld T; Schwab ME
    J Exp Med; 2004 Oct; 200(8):1027-38. PubMed ID: 15492125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multiple sclerosis: from the immune system to inflammatory demyelination and irreversible neurodegeneration].
    Sindic CJ
    Bull Mem Acad R Med Belg; 2002; 157(7-9):391-8; discussion 398-400. PubMed ID: 12647378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo distribution of bismuth in the mouse brain: influence of long-term survival and intracranial placement on the uptake and transport of bismuth in neuronal tissue.
    Larsen A; Stoltenberg M; Søndergaard C; Bruhn M; Danscher G
    Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):188-96. PubMed ID: 16128915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal immune system and brain dialogue implicated in neuroinflammatory and neurodegenerative diseases.
    Deretzi G; Kountouras J; Polyzos SA; Zavos C; Giartza-Taxidou E; Gavalas E; Tsiptsios I
    Curr Mol Med; 2011 Nov; 11(8):696-707. PubMed ID: 21902649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental strategies to promote central nervous system remyelination in multiple sclerosis: insights gained from the Theiler's virus model system.
    Miller DJ; Asakura K; Rodriguez M
    J Neurosci Res; 1995 Jun; 41(3):291-6. PubMed ID: 7563222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review article: serotonin receptors and transporters -- roles in normal and abnormal gastrointestinal motility.
    Gershon MD
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 7():3-14. PubMed ID: 15521849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axonal loss in multiple sclerosis: a pathological survey of the corticospinal and sensory tracts.
    DeLuca GC; Ebers GC; Esiri MM
    Brain; 2004 May; 127(Pt 5):1009-18. PubMed ID: 15047586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial dysfunction plays a key role in progressive axonal loss in Multiple Sclerosis.
    Andrews HE; Nichols PP; Bates D; Turnbull DM
    Med Hypotheses; 2005; 64(4):669-77. PubMed ID: 15694681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway.
    Sepulcre J; Goñi J; Masdeu JC; Bejarano B; Vélez de Mendizábal N; Toledo JB; Villoslada P
    Arch Neurol; 2009 Feb; 66(2):173-9. PubMed ID: 19204153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal administration of interferon beta bypasses the blood-brain barrier to target the central nervous system and cervical lymph nodes: a non-invasive treatment strategy for multiple sclerosis.
    Ross TM; Martinez PM; Renner JC; Thorne RG; Hanson LR; Frey WH
    J Neuroimmunol; 2004 Jun; 151(1-2):66-77. PubMed ID: 15145605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple sclerosis preceding CNS lymphoma: a case report.
    Yang JH; Wu SL
    Acta Neurol Taiwan; 2007 Jun; 16(2):92-7. PubMed ID: 17685133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term study of brain 1H-MRS study in multiple sclerosis: effect of glatiramer acetate therapy on axonal metabolic function and feasibility of long-Term H-MRS monitoring in multiple sclerosis.
    Khan O; Shen Y; Bao F; Caon C; Tselis A; Latif Z; Zak I
    J Neuroimaging; 2008 Jul; 18(3):314-9. PubMed ID: 18304034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Axonal damage in multiple sclerosis].
    Arbizu-Urdiain T; Martínez-Yélamos A
    Rev Neurol; 2000 Jun 16-30; 30(12):1223-7. PubMed ID: 10935255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The chemokine system in neuroinflammation: an update.
    Ransohoff RM
    J Infect Dis; 2002 Dec; 186 Suppl 2():S152-6. PubMed ID: 12424691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axonal transport and neuronal transcytosis of trophic factors, tracers, and pathogens.
    von Bartheld CS
    J Neurobiol; 2004 Feb; 58(2):295-314. PubMed ID: 14704960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal dysfunction in multiple sclerosis.
    Fowler CJ; Henry MM
    Semin Neurol; 1996 Sep; 16(3):277-9. PubMed ID: 9085478
    [No Abstract]   [Full Text] [Related]  

  • 20. Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis.
    Evangelou N; Esiri MM; Smith S; Palace J; Matthews PM
    Ann Neurol; 2000 Mar; 47(3):391-5. PubMed ID: 10716264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.